S. MUOIO & CO. LLC - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
S. MUOIO & CO. LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$964,000
+31.3%
52,468
+31.2%
1.05%
+25.5%
Q3 2020$734,00040,0000.83%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q1 2021
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 38,300$555,0000.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 34,571$501,0000.01%
Acrospire Investment Management LLC 300$4,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 25,798$374,0000.00%
RHUMBLINE ADVISERS 14,614$212,0000.00%
BlackRock Investment Management, LLC 47,237$685,0000.00%
BlackRock Fund Advisors 336,772$4,883,0000.00%
NORTHERN TRUST CORP 135,559$1,966,0000.00%
NEW YORK STATE COMMON RETIREMENT FUND 11,406$165,0000.00%
STRS OHIO 1,500$21,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders